Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Isofol Medical
isofol medical ab (publ) is a drug development company within the field of oncology developing arfolitixorin (modufolin®), primarily as a treatment for advanced colorectal cancer and as a rescue drug after high-dose methotrexate treatment in osteosarcoma (bone cancer). through a worldwide exclusive license agreement, isofol holds the rights to develop and commercialise arfolitixorin (modufolin®) within oncology with access to the unique patented production process and the production capabilities of merck kgaa, darmstadt, germany. isofol medical ab is traded on the nasdaq first north premier. certified adviser is fnca sweden ab. about arfolitixorin (modufolin®) arfolitixorin (modufolin®) is developed to increase the efficacy of the cytotoxic agent 5-fluorouracil (5fu) and as a rescue drug after high-dose methotrexate treatment. arfolitixorin (modufolin®) is suitable for all patients irrespective of their capacity to activate folates since it doesn’t require metabolic activation to exert
Frequently asked questions about Isofol Medical
Let us help answer the most common questions you might have.
Where is Isofol Medical located?
Isofol Medical's headquarters is located at Gothenburg, Västra Götaland, Sweden
What is Isofol Medical's official website?
Isofol Medical's official website is isofolmedical.se
How many employees does Isofol Medical have?
Isofol Medical has 16 employees
What industry does Isofol Medical belong to?
Isofol Medical is in the industry of: Pharmaceuticals
What are Isofol Medical's social media links?
Isofol Medical Linkedin page
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
